Invus
North America, New York, United States, New York
Description
Invus recognizes that every company is unique and that extraordinary business performance cannot be achieved by following a formulaic.
Investor Profile
Invus has made 251 investments, with 29 in the past 12 months and 18% as lead.
Stage Focus
- Series B (24%)
- Series C (17%)
- Post Ipo Equity (17%)
- Series A (16%)
- Series Unknown (13%)
- Series D (6%)
- Private Equity (2%)
- Series E (2%)
- Seed (1%)
- Convertible Note (1%)
Country Focus
- United States (75%)
- France (7%)
- Switzerland (3%)
- United Kingdom (2%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- China (2%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Sweden (2%)
- Finland (2%)
- Ireland (1%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
- Canada (1%)
- Jordan (1%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Life Science
- Pharmaceutical
- Biopharma
- Software
- Genetics
- Information Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
